You are here

  • Home
  • Archive
  • Volume 88, Issue 10
  • Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Article metrics

Article menu

Download PDFPDF

Neuromuscular
Research paper
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

 

Online download statistics by month:

Online download statistics by month: August 2017 to March 2024

AbstractFullPdf
Aug 20179931045301
Sep 2017882913259
Oct 2017620663268
Nov 2017226232104
Dec 201728228181
Jan 201815915877
Feb 201839137586
Mar 201830329873
Apr 201818818745
May 20189910443
Jun 2018818248
Jul 2018575543
Aug 2018717180
Sep 2018595968
Oct 201810710780
Nov 201810610689
Dec 201810210274
Jan 2019848374
Feb 20196867137
Mar 20195252185
Apr 20199492230
May 20194846268
Jun 20195656269
Jul 20194040233
Aug 20194444280
Sep 20194040227
Oct 20194747249
Nov 20193938230
Dec 20193434151
Jan 20206766147
Feb 20205654135
Mar 20207168165
Apr 20204343253
May 2020383888
Jun 2020232364
Jul 2020403963
Aug 2020605766
Sep 2020564934
Oct 2020656336
Nov 2020686347
Dec 2020383227
Jan 2021494327
Feb 2021484345
Mar 2021515042
Apr 2021706844
May 2021636137
Jun 2021747339
Jul 2021777743
Aug 2021838370
Sep 2021636140
Oct 2021666452
Nov 2021494444
Dec 2021899038
Jan 2022666840
Feb 2022696535
Mar 2022797551
Apr 2022938457
May 202210210046
Jun 2022656326
Jul 2022777635
Aug 2022615916
Sep 2022888530
Oct 2022726923
Nov 2022514936
Dec 2022636326
Jan 2023666330
Feb 2023747726
Mar 202310211040
Apr 2023849141
May 2023757235
Jun 2023899219
Jul 202312412947
Aug 2023909231
Sep 2023727327
Oct 202312112636
Nov 202311411821
Dec 202313713632
Jan 2024554431
Feb 20241039363
Mar 202414113146
Total911291326944